“…In patients with SCA1, oculomotor disorders, bulbar syndrome, and respiratory disorders have also been reported [ 16 ]. Nevertheless, SCA1 also leads to neuropsychiatric problems, including cognitive impairment, anxiety, apathy, and depression, which can be seen in both human and mouse models [ 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 ]. In addition, changes in functions associated with hippocampal plasticity have been described [ 9 , 25 , 26 ].…”